title: [Different treatment modalities of patients with stage III lung cancer].
abstract: OBJECTIVE
  In order to improve the survival-rates and study the long-term therapeutic effect of stage III lung cancer patients with different treatment modalities.
  
  
  METHODS
  From 1995 to 2004, 1921 patients of stage III lung cancer treated at our hospital were retrospectively analyzed to compare the long-term therapeutic effect of different treatment modalities. There were 606 cases in the combined therapy group (mainly surgical with combined treatment of chemotherapy & radiotherapy), 317 cases in the surgery alone group and 998 cases in the non-surgical group. The 1, 3, 5-year survival rates of these three groups were 66.0% (400/606) vs. 62.7% (199/317) vs. 51.2% (511/998), 32.34% (196/606) vs. 21.45% (68/317) vs. 8.15% (81/998), 19.31% (117/606) vs. 13.2% (42/317) vs. 4.2% (42/998) respectively. In comparison, 1, 3, 5-year survival rates of the combined therapy group was higher than the surgery alone and non-surgical groups; Significant differences in 1-year survival rates were found between the combined therapy group and the surgery alone group or the non-surgical group (P < 0.01) and significant differences in 3, 5-year survival rates among these three groups.
  
  
  CONCLUSIONS
  The combined therapy of radical resection with chemotherapy and radiotherapy is the best treatment modality for stage III lung cancer.
authors.affiliation: Department of Thoracic Tumor, Beijing Tuberculosis & Thoracic Tumor Hospital, Beliing 101149, China.
authors.forename: Da-ping
authors.initials: DP
authors.lastname: Yu
authors.forename: Yong
authors.initials: Y
authors.lastname: Duan
authors.forename: Zi-tong
authors.initials: ZT
authors.lastname: Wang
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011013:Pneumonectomy; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome